Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Ablation of CONseCutive atriaL Tachycardia gUided by Ultra-high-DEnsity Mapping

NCT05239364 is registered in ClinicalTrials.gov with Evangelical Hospital Düsseldorf as lead sponsor.

NCT NCT05239364
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05239364 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Ablation of CONseCutive atriaL Tachycardia gUided by Ultra-high-DEnsity Mapping
Lead sponsor
Evangelical Hospital Düsseldorf
Phase
Not applicable
Overall status
Recruiting
Start date
December 22, 2020
Completion date
June 30, 2027
Enrollment
100 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

arrhythmias, cardiac, atrial tachycardia, heart arrhythmia, heart diseases